小鼠模型市場規模、佔有率及成長分析（依模型類型、技術、應用、最終用戶及地區分類）－2025-2032年產業預測

預計到 2023 年，全球小鼠模型市場規模將達到 16 億美元，到 2024 年將達到 17.1 億美元，到 2032 年將達到 28.4 億美元，預測期（2025-2032 年）的複合年成長率為 6.6%。

全球小鼠模型市場受到癌症、糖尿病和心血管疾病等慢性疾病發生率上升的顯著影響，促使醫療保健系統優先考慮早期診斷和治療方法創新。由於小鼠在遺傳、生物學和行為學方面與人類具有相似性，製藥和生物技術公司擴大利用小鼠作為重要的臨床前測試模型，這有助於了解疾病進展並評估治療方法。慢性疾病盛行率的快速成長推動了研發領域的巨額投資，從而導致對先進小鼠模型的需求不斷成長，以促進藥物發現。此外，基因工程技術的快速發展，特別是CRISPR-Cas9技術的進步，正在透過實現基因改造和人源化模型的精確構建，改變這一領域，提高了臨床前試驗的準確性，並加速了治療方法進展。

全球小鼠模型市場促進因素

慢性疾病（包括癌症、糖尿病和心血管疾病）的日益流行，正顯著推動全球小鼠模型市場的成長。小鼠模型在闡明疾病機制和評估潛在治療性介入方面發揮關鍵作用。它們在加速藥物研發方面的重要性不容忽視，因為研究人員越來越依賴這些模型來創新和開發有效的治療方法。對先進治療方法的日益成長的需求凸顯了生物醫學研究領域對小鼠模型的必要性，從而推動旨在改善患者預後和應對與慢性疾病相關的緊迫醫療保健挑戰的進展。

全球小鼠模型市場限制因素

全球小鼠模型市場面臨許多挑戰，主要源自於實驗室小鼠的繁殖、飼養和圈養成本高。對專業設施的需求、對專業人員的聘用以及對嚴格倫理標準的遵守，都顯著增加了營運成本。這些經濟壁壘限制了小型研究機構的進入，使其難以有效參與市場。此外，這些限制在資源本就有限的發展中地區尤其嚴重。因此，整體市場成長受到阻礙，使得眾多機構難以為研發進步做出貢獻。

全球小鼠模型市場趨勢

全球小鼠模型市場正呈現顯著趨勢，製藥和生物技術公司擴大採用人源化和基因轉殖小鼠模型。這些先進的模型能夠更精確地模擬人類疾病狀態，從而提高臨床前試驗的預測準確性。隨著企業尋求加速藥物研發進程並降低臨床試驗失敗率，這些先進小鼠模型的需求持續成長。這種轉變不僅推動了產業創新，也為更有效的治療性介入鋪平了道路，鞏固了先進小鼠模型在生物醫學研究中的關鍵作用。

目錄

介紹

• 調查目標
• 調查範圍
• 定義

調查方法

• 資訊收集
• 二手資料和一手資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分市場機會分析

市場動態與展望

• 市場概覽
• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制與挑戰
• 波特分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 關鍵投資機會
• 市場生態系統
• 市場吸引力指數（2024）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 技術評估
• 監管環境

依型號類型分類的滑鼠模型市場規模及複合年成長率（2025-2032 年）

• 市場概覽
• 近交系小鼠
• 非近交系小鼠
• 基因轉殖小鼠（GEM）
• 雜交/共基因小鼠

按技術分類的小鼠模型市場規模及複合年成長率（2025-2032 年）

• 市場概覽
• CRISPR/基因編輯
• 胚胎幹細胞注射
• 顯微注射/核移植
• 常規育種和再誘導

按應用領域分類的滑鼠模型市場規模及複合年成長率（2025-2032 年）

• 市場概覽
• 藥物發現與開發
• 疾病模式（腫瘤學、免疫學、神經病學、代謝學）
• 毒理學與安全藥理學
• 個人化醫療/轉化研究

依最終使用者分類的滑鼠市場規模及複合年成長率（2025-2032 年）

• 市場概覽
• 製藥和生物技術公司
• 學術和研究機構
• 受託研究機構（CRO）
• 政府和監管機構

小鼠模型市場規模及複合年成長率（2025-2032）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業的市場定位（2024 年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市佔率分析（2024 年）
• 主要企業公司簡介
  • 公司詳情
  • 產品系列分析
  • 依業務板塊進行公司股票分析
  • 2022-2024年營收年比比較

主要企業簡介

• Charles River Laboratories
• The Jackson Laboratory
• Taconic Biosciences
• Envigo
• Janvier Labs
• GenOway
• Cyagen Biosciences
• BioCytogen
• InVivo Biosystems
• Ozgene
• Horizon Discovery
• Crown Bioscience
• The Jackson Laboratory for Genomic Medicine
• GenOway SA
• Transgenic Animal Model Technologies（TAMT）
• Wuxi AppTec
• LAB Research Models & Services
• Biocytogen Pharma Technology
• GeneChem Co., Ltd.
• Shanghai Model Organism Center

結論與建議

Global Mice Model Market size was valued at USD 1.6 billion in 2023 and is poised to grow from USD 1.71 billion in 2024 to USD 2.84 billion by 2032, growing at a CAGR of 6.6% during the forecast period (2025-2032).

The Global Mice Model Market is significantly influenced by the rising incidence of chronic diseases such as cancer, diabetes, and cardiovascular conditions, prompting healthcare systems to emphasize early diagnosis and therapeutic innovations. Pharmaceutical and biotech companies increasingly utilize mice as essential preclinical testing models due to their genetic, biological, and behavioral parallels with humans, thereby enhancing the understanding of disease progression and therapy evaluation. This surge in chronic disease prevalence drives substantial research and development investments, subsequently increasing the demand for sophisticated mice models to facilitate drug discovery. Additionally, the rapid evolution of genetic engineering techniques, particularly CRISPR-Cas9, is transforming the sector by enabling precise creation of transgenic and humanized models, subsequently enhancing the accuracy of preclinical studies and expediting therapeutic advancements.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Mice Model market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Mice Model Market Segments Analysis

Global Mice Model Market is segmented by Model Type, Technology, Application, End-User and region. Based on Model Type, the market is segmented into Inbred Mice, Outbred Mice, Genetically Engineered Mice (GEM) and Hybrid / Congenic Mice. Based on Technology, the market is segmented into CRISPR / Gene-Editing, Embryonic Stem Cell Injection, Microinjection / Nuclear Transfer and Traditional Breeding & Rederivation. Based on Application, the market is segmented into Drug Discovery & Development, Disease Modeling (Oncology, Immunology, Neurology, Metabolic), Toxicology & Safety Pharmacology and Personalized / Translational Research. Based on End-User, the market is segmented into Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Contract Research Organisations (CROs) and Government & Regulatory Agencies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Mice Model Market

The rising prevalence of chronic illnesses, including cancer, diabetes, and cardiovascular diseases, significantly propels the growth of the global mice model market. Mice models play a pivotal role in understanding disease mechanisms and assessing potential therapeutic interventions. Their importance in facilitating drug discovery cannot be overstated, as researchers increasingly rely on these models to innovate and develop effective treatments. This escalating demand for advanced therapies underscores the necessity of mice models in the biomedical research landscape, driving advancements that aim to improve patient outcomes and address the urgent healthcare challenges associated with chronic diseases.

Restraints in the Global Mice Model Market

The global Mice Model market encounters several challenges primarily due to the substantial costs linked to the breeding, upkeep, and housing of laboratory mice. The need for specialized facilities, the employment of skilled personnel, and adherence to strict ethical standards considerably elevate operational expenses. These financial barriers can restrict access for smaller research institutions, hindering their ability to participate effectively in this market. Additionally, these constraints disproportionately impact developing regions, where resources are already limited. As a result, the overall growth of the market is stymied, making it difficult for a wide range of institutions to contribute to advancements in research and development.

Market Trends of the Global Mice Model Market

The Global Mice Model market is experiencing a significant trend towards the increased adoption of humanized and transgenic mice models among pharmaceutical and biotech companies. These advanced models offer enhanced capabilities for accurately simulating human disease conditions, which in turn improves the predictive value of preclinical studies. As companies aim to expedite drug discovery processes and minimize failure rates during clinical trials, the demand for these sophisticated mice models continues to grow. This shift not only fuels innovation within the industry but also establishes a pathway for more effective therapeutic interventions, solidifying the essential role of advanced mice models in biomedical research.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technology Assessment
• Regulatory Landscape

Global Mice Model Market Size by Model Type & CAGR (2025-2032)

• Market Overview
• Inbred Mice
• Outbred Mice
• Genetically Engineered Mice (GEM)
• Hybrid / Congenic Mice

Global Mice Model Market Size by Technology & CAGR (2025-2032)

• Market Overview
• CRISPR / Gene-Editing
• Embryonic Stem Cell Injection
• Microinjection / Nuclear Transfer
• Traditional Breeding & Rederivation

Global Mice Model Market Size by Application & CAGR (2025-2032)

• Market Overview
• Drug Discovery & Development
• Disease Modeling (Oncology, Immunology, Neurology, Metabolic)
• Toxicology & Safety Pharmacology
• Personalized / Translational Research

Global Mice Model Market Size by End-User & CAGR (2025-2032)

• Market Overview
• Pharmaceutical & Biotechnology Companies
• Academic & Research Institutes
• Contract Research Organisations (CROs)
• Government & Regulatory Agencies

Global Mice Model Market Size & CAGR (2025-2032)

• North America (Model Type, Technology, Application, End-User)
  • US
  • Canada
• Europe (Model Type, Technology, Application, End-User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Model Type, Technology, Application, End-User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Model Type, Technology, Application, End-User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Model Type, Technology, Application, End-User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Charles River Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• The Jackson Laboratory
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Taconic Biosciences
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Envigo
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Janvier Labs
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GenOway
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cyagen Biosciences
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioCytogen
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• InVivo Biosystems
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ozgene
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Horizon Discovery
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Crown Bioscience
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• The Jackson Laboratory for Genomic Medicine
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GenOway SA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Transgenic Animal Model Technologies (TAMT)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Wuxi AppTec
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LAB Research Models & Services
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biocytogen Pharma Technology
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GeneChem Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shanghai Model Organism Center
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations